OICR-9429-N-C2-NH2

Modify Date: 2025-08-25 10:06:10

OICR-9429-N-C2-NH2 Structure
OICR-9429-N-C2-NH2 structure
Common Name OICR-9429-N-C2-NH2
CAS Number 2407457-55-8 Molecular Weight 597.67
Density N/A Boiling Point N/A
Molecular Formula C31H38F3N7O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of OICR-9429-N-C2-NH2


OICR-9429-N-C2-NH2 is a ligand for Wd40 repeat domain protein 5 (WDR5) extracted from patent WO2019246570A1, intermediate 2. OICR-9429-N-C2-NH2 can be used in the synthesis of PROTACs[1].

 Names

Name OICR-9429-N-C2-NH2

 OICR-9429-N-C2-NH2 Biological Activity

Description OICR-9429-N-C2-NH2 is a ligand for Wd40 repeat domain protein 5 (WDR5) extracted from patent WO2019246570A1, intermediate 2. OICR-9429-N-C2-NH2 can be used in the synthesis of PROTACs[1].
Related Catalog
Target

Ligand for Target Protein for PROTAC[1]

In Vitro PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].
References

[1]. Jin J, et, al. Wd40 repeat domain protein 5 (wdr5) degradation / disruption compounds and methods of use. WO2019246570A1.

[2]. Chung CW, et, al. Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. ACS Chem Biol. 2020 Sep 18;15(9):2316-2323.

 Chemical & Physical Properties

Molecular Formula C31H38F3N7O2
Molecular Weight 597.67
Storage condition 2-8°C
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

OICR-9429-N-C2-NH2 suppliers

OICR-9429-N-C2-NH2 price

Related Compounds: More...
OICR 9429
1801787-56-3
Thalidomide-NH-PEG1-C2-NH2
2138439-12-8
Fmoc-NH-PEG3-C2-NH2
906126-25-8
Thalidomide-NH-PEG2-C2-NH2 TFA
2097509-36-7
Pomalidomide-amido-PEG3-C2-NH2
2328070-52-4
Thalidomide-NH-PEG2-C2-NH2
2093416-32-9
Fmoc-NH-PEG5-C2-NH2
2093277-71-3
Thalidomide-NH-PEG2-C2-NH2 hydrochloride
2245697-87-2
Boc-C2-NH2
15231-41-1
Poly(oxy-1,2-ethanediyl), I+/--[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-I-[3-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]propoxy]-
1240508-24-0
(S)-tert-Butyl 3-(chlorosulfonyl)pyrrolidine-1-carboxylate
1932548-81-6
2-(4-Nitro-1,3-dioxoisoindolin-2-yl)pentanedioic Acid-d4
1416575-82-0
I(2)-D-Glucopyranosylamine, N-(phenylmethylene)-, 2,3,4,6-tetrakis(2,2-dimethylpropanoate), [N(E)]-
287966-95-4
2,4,7-trimethyl-1H-indene-1,3(2H)-dione
1126837-47-5
3-Dichloromethyl-5-ethoxy-1,2,4-thiadiazole
1255929-52-2
[(1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl]methanesulfonyl fluoride
2090681-89-1
(S)-2-Amino-3-(2-fluoro-6-methoxyphenyl)propanoic acid
1270092-22-2
l-Cysteine, S-((acetylamino)methyl)-N-(N-(N-(N-(N-(N2-(N-(N-(N-(N2-((1,1-dimethylethoxy)carbonyl)-l-asparaginyl)-l-phenylalanyl)-l-phenylalanyl)-l-tryptophyl)-N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysyl)-l-threonyl)-l-phenylalanyl)-l-threonyl)-l-seryl)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester
76408-83-8
Somatostatin (sheep reduced), N-((1,1-dimethylethoxy)carbonyl)-3-(S-((acetylamino)methyl)-l-cysteine)-4-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-9-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-14-(S-((acetylamino)methyl)-l-cysteine)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester
76408-92-9